Oculus posts record sales in fourth quarter

<p>Petaluma medical technology startup Oculus Innovative Sciences saw sales rise 23 percent to a record $2.7 million in the fourth quarter, company officials said Thursday.</p><p>Oculus lost $1.7 million in the quarter, up 13 percent from the same period last year.</p><p>Oculus makes an infection-fighting liquid called Microcyn that is sold in the U.S., Mexico, Europe, India, China and parts of the Middle East.</p><p>Microcyn products are aimed at the dermatology, wound care, oral care, cosmeceutical and veterinary care markets.</p><p>Oculus is partnering with drug development companies to launch prescription versions in the U.S.</p><p>Sales grew in the U.S., Mexico, Europe and China during the quarter ended March 31, offset by declines in India and the Middle East.</p><p>Expenses rose 22 percent, driven by research and development and regulatory costs.</p><p>For the full year, Oculus posted a $7.9 million loss on $9.8 million in sales.</p><p>Oculus has about 35 employees at its Petaluma headquarters.</p>